Mendelian Reports High Cost of Rare Disease Patients
Executive Summary
New research commissioned by health tech company Mendelian found that rare disease patients have cost NHS England in excess of £4.3bn over the past ten years. The company is hoping its technology can enable physicians and hospitals to save money and diagnose patients faster.